AllPeptides.eu - Advanced Peptide Research
    Research-use-only hub
    2 variants

    Educational protocol hub

    AICAR: protocol variants and reconstitution resources

    Educational hub for AICAR, grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.

    What this hub covers

    This page groups the available AICAR protocol variants so readers can choose the exact vial-size guide without mixing formats.

    Reconstitution workflow

    Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.

    Research-only context

    All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.

    Available protocol variants

    Choose the exact guide you want to view.

    AICAR

    50mg

    AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK), earning it the nickname 'exercise in a pill' after studies showed sedentary animals on AICAR experienced dramatic improvements in endurance. AICAR is banned in sports (WADA) and is not approved for therapeutic use in humans. This protocol outlines a daily subcutaneous approach for research purposes only.

    View protocol

    AICAR

    100mg

    AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is an AMP analogue that activates AMPK and is studied as an "exercise mimetic" at the cellular level. Research-use literature describes subcutaneous administration of 1–3 mg once daily with gradual titration.

    View protocol

    Related research resources

    Internal links that help readers and search engines understand this peptide topic cluster.

    References

    1. U.S. Anti-Doping Agency (USADA) — AICAR and Prohibited AMPK Activators
      View Source
    2. Narkar VA et al. Cell 2008 — AMPK and PPARdelta agonists are exercise mimetics.
      View Source
    3. PMC (2010) — AICAR normalizes skeletal muscle dysregulation in obesity
      View Source
    4. PubMed (2013) — Acadesine Phase I/II: maximum tolerated dose 210 mg/kg IV
      View Source
    5. Cell Signaling Technology — AICAR (Acadesine): AMPK activation mechanism
      View Source

    Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu